Related Experiment Video

Updated: Jan 14, 2026

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
06:51

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents

Published on: August 10, 2018

8.1K

Targeting the mutant androgen receptor with PROTACs in spinal and bulbar muscular atrophy

Changwoo Lee1, Janghoo Lim2

  • 1Department of Genetics, Yale School of Medicine, New Haven, CT, USA.

Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|October 17, 2025
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Androgen receptorKennedy's diseasePROTACSpinal and bulbar muscular atrophy

More Related Videos

Delivery of Therapeutic Agents Through Intracerebroventricular ICV and Intravenous IV Injection in Mice
05:55

Delivery of Therapeutic Agents Through Intracerebroventricular ICV and Intravenous IV Injection in Mice

Published on: October 3, 2011

63.0K
Direct Intraventricular Delivery of Drugs to the Rodent Central Nervous System
14:55

Direct Intraventricular Delivery of Drugs to the Rodent Central Nervous System

Published on: May 12, 2013

61.7K

Related Experiment Videos

Last Updated: Jan 14, 2026

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
06:51

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents

Published on: August 10, 2018

8.1K
Delivery of Therapeutic Agents Through Intracerebroventricular ICV and Intravenous IV Injection in Mice
05:55

Delivery of Therapeutic Agents Through Intracerebroventricular ICV and Intravenous IV Injection in Mice

Published on: October 3, 2011

63.0K
Direct Intraventricular Delivery of Drugs to the Rodent Central Nervous System
14:55

Direct Intraventricular Delivery of Drugs to the Rodent Central Nervous System

Published on: May 12, 2013

61.7K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

2.3K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.3K

Articles linked to this work by shared authors, journal, and citation graph.

Meniscus Morphology-Based Prediction of Backup Roll Eccentricity for Stable Slot-Die Coating on Polymer Films.

Polymers·2026

Locus-Specific Genetic Associations at the DAOA Gene in Schizophrenia and Bipolar Disorder.

Advanced genetics (Hoboken, N.J.)·2026

Physician behavior for "invisible" treatment; Korean herbal medicine doctor's treatment covered by auto insurance.

PloS one·2026

Aromatic interactions surrounding the Asp-X-Glu motif stabilize the active site of HYAL1 and PH20.

Biochimica et biophysica acta. Proteins and proteomics·2026

Oligodendrocyte dysfunction contributes to motor deficits and Purkinje cell axonopathy in spinocerebellar ataxia type 1.

The Journal of clinical investigation·2026

PGC-1α pathway dysregulation disrupts myofiber specification in a mouse model of SBMA.

JCI insight·2026

A brief acceptance and commitment therapy intervention for individuals at risk of neurodegenerative disease: A translational study in inherited prion disease.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026

NEMO (IKKγ) citrullination in microglia promotes neuroinflammation in the post-ischemic brain.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026

Genetic and pharmacological evidence linking CB1R signaling to hippocampal GABAergic dysfunction in ASD mouse model.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026

PDE5 inhibition restores mitochondrial function and improves neurobehavioral outcomes after repeated mild blast TBI.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026

Digital signatures of fatigue and wearing-off symptoms in patients with multiple sclerosis under natalizumab.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026

40 Hz vibrotactile stimulation ameliorates amyloid pathology and cognitive deficits in 5xFAD mice and is associated with alterations in Piezo1, ERK, and GSK-3β/p65 signaling.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us